Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Fomepizole, an effective antidote to ethylene glycol poisoning

March 29, 1999

Dual dopamine D1/D5 antagonist blocks the rewarding effects of cocaine in humans

March 24, 1999

Bupropion more effective than nicotine patches in smoking cessation therapy

March 8, 1999

Glaxo Wellcome seeks approval for Zyban in the E.U.

March 4, 1999

Multiple methods of nicotine replacement increase abstinence rates in smokers

Feb. 24, 1999

Cantab completes acquisition of drug addiction programs from ImmuLogic

Feb. 3, 1999

Studies in knockout mice support the role of CB1 receptor in opiate addiction

Jan. 26, 1999

Potent and selective DAT ligand identified by RTI and Emory University

Jan. 22, 1999

Novel pure mu/kappa-opioid receptor antagonist as a lead in the field of drug abuse therapy

Jan. 20, 1999

Orphan drug for iron overload offered for licensing by Biomedical Frontiers

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...